These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34187624)
1. Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema. Ocak M; Nain E; Akarsu A; Sahiner UM; Sekerel BE; Soyer O Allergy Asthma Proc; 2021 Jul; 42(4):325-332. PubMed ID: 34187624 [No Abstract] [Full Text] [Related]
2. Health-related quality of life among children with hereditary angioedema. Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in Danish children with hereditary angioedema. Aabom A; Nguyen D; Fisker N; Bygum A Allergy Asthma Proc; 2017 Nov; 38(6):440-446. PubMed ID: 29046193 [TBL] [Abstract][Full Text] [Related]
4. Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema? Ocak M; Nain E; Şahiner ÜM; Akin MŞ; Karabiber E; Şekerel BE; Soyer Ö Pediatr Dermatol; 2021 Jan; 38(1):143-148. PubMed ID: 33275322 [TBL] [Abstract][Full Text] [Related]
5. The relationship between anxiety and quality of life in children with hereditary angioedema. Kessel A; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Engel-Yeger B Pediatr Allergy Immunol; 2017 Nov; 28(7):692-698. PubMed ID: 28692169 [TBL] [Abstract][Full Text] [Related]
6. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States. Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life and its risk factors in Chinese hereditary angioedema patients. Liu S; Wang X; Xu Y; Xu Q; Zhi Y Orphanet J Rare Dis; 2019 Aug; 14(1):191. PubMed ID: 31395105 [TBL] [Abstract][Full Text] [Related]
8. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286 [TBL] [Abstract][Full Text] [Related]
9. Effect of COVID-19 on hereditary angioedema activity and quality of life. Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710 [No Abstract] [Full Text] [Related]
10. National audit of a hereditary and acquired angioedema cohort in New Zealand. Lindsay K; Chua I; Jordan A; Stephens S Intern Med J; 2022 Dec; 52(12):2124-2129. PubMed ID: 34346157 [TBL] [Abstract][Full Text] [Related]
11. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Jacobs J; Neeno T Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830 [TBL] [Abstract][Full Text] [Related]
13. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study. Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595 [TBL] [Abstract][Full Text] [Related]
14. The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews. Jean-Baptiste M; Itzler R; Prusty S; Supina D; Martin ML Orphanet J Rare Dis; 2022 Jun; 17(1):232. PubMed ID: 35710442 [TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey. Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128 [TBL] [Abstract][Full Text] [Related]
16. Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms. Nygren A; Nordenfelt P; Lindfors A; Mallbris L; Björkander J; Wahlgren CF Acta Paediatr; 2016 May; 105(5):529-34. PubMed ID: 26821285 [TBL] [Abstract][Full Text] [Related]
18. Prospective Study on the Efficacy and Impact of Cascade Screening and Evaluation of Hereditary Angioedema (CaSE-HAE). Wong JCY; Chiang V; Lam K; Tung E; Au EYL; Lau CS; Li PH J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2896-2903.e2. PubMed ID: 35964924 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children. Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784 [TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]